Correlation Between Biomarin Pharmaceutical and Agenus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Agenus Inc, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Agenus.

Diversification Opportunities for Biomarin Pharmaceutical and Agenus

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Biomarin and Agenus is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Agenus go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceutical and Agenus

Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Agenus. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 3.85 times less risky than Agenus. The stock trades about -0.04 of its potential returns per unit of risk. The Agenus Inc is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  405.00  in Agenus Inc on November 1, 2024 and sell it today you would lose (51.00) from holding Agenus Inc or give up 12.59% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biomarin Pharmaceutical  vs.  Agenus Inc

 Performance 
       Timeline  
Biomarin Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Biomarin Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Agenus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Agenus is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Biomarin Pharmaceutical and Agenus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceutical and Agenus

The main advantage of trading using opposite Biomarin Pharmaceutical and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.
The idea behind Biomarin Pharmaceutical and Agenus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope